Abstract
Oxidative damage has been implicated in retinal ganglion cell (RGC) death after optic nerve transection (ONT) and during glaucomatous neuropathy. Here, we analyzed the expression and cell protective role of thioredoxins (TRX), key regulators of the cellular redox state, in RGCs damaged by pharmacologically induced oxidative stress, ONT and elevated intraocular pressure (IOP). The endogenous level of thioredoxin-1 (TRX1) and thioredoxin-2 (TRX2) in RGCs after axotomy and in RGC-5 cells after glutamate/buthionine sulfoximine (BSO) treatment showed upregulation of TRX2, whereas no significant change was observed in TRX1 expression. The increased level TRX-interacting protein (TXNIP) in the retinas was observed 2 and 5 weeks after IOP elevation. TRX1 level was decreased at 2 weeks and more prominently at 5 weeks after IOP increase. No change in TRX2 levels in response to IOP change was observed. Overexpression of TRX1 and TRX2 in RGC-5 treated with glutamate/BSO increased the cell survival by 2- and 3-fold 24 and 48 h after treatment, respectively. Overexpression of these proteins in the retina increased the survival of RGCs by 35 and 135% 7 and 14 days after ONT, respectively. In hypertensive eyes, RGC loss was approximately 27% 5 weeks after IOP elevation compared to control. TRX1 and TRX2 overexpression preserved approximately 45 and 37% of RGCs, respectively, that were destined to die due to IOP increase.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dezawa M, Takano M, Negishi H et al (2002) Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach. Micron 33:1–6
Geiger LK, Kortuem KR, Alexejun C, Levin LA (2002) Reduced redox state allows prolonged survival of axotomized neonatal retinal ganglion cells. Neuroscience 109:635–642
Ishii Y, Kwong JM, Caprioli J (2003) Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. Invest Ophthalmol Vis Sci 44:1982–1992
Ishikawa H, Takano M, Matsumoto N et al (2005) Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode. Gene Ther 12:289–298
Koeberle PD, Ball AK (1999) Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells. Exp Neurol 158:366–381
Kumar DM, Agarwal N (2007) Oxidative stress in glaucoma: a burden of evidence. J Glaucoma 16:334–343
Kwong JM, Lalezary M, Nguyen JK et al (2006) Co-expression of heat shock transcription factors 1 and 2 in rat retinal ganglion cells. Neurosci Lett 405:191–195
Masutani H, Ueda S, Yodoi J (2005) The thioredoxin system in retroviral infection and apoptosis. Cell Death Differ 12:991–998
Munemasa Y, Ahn JH, Kwong JM et al (2009) Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma. Gene Ther 16:17–25
Munemasa Y, Kim SH, Ahn JH et al (2008) Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress. Invest Ophthalmol Vis Sci 49:3535–3543
Nguyen SM, Alexejun CN, Levin LA (2003) Amplification of a reactive oxygen species signal in axotomized retinal ganglion cells. Antioxid Redox Signal 5:629–634
Nishiyama A, Matsui M, Iwata S et al (1999) Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274:21645–21650
Nonn L, Williams RR, Erickson RP et al (2003) The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 23:916–922
Piri N, Song M, Kwong JM et al (2007) Modulation of alpha and beta crystallin expression in rat retinas with ocular hypertension-induced ganglion cell degeneration. Brain Res 1141:1–9
Saitoh M, Nishitoh H, Fujii M et al (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17:2596–2606
Tanito M, Kwon YW, Kondo N (2005) Cytoprotective effects of geranylgeranylacetone against retinal photooxidative damage. J Neurosci 25:2396–2404
Tezel G (2006) Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25:490–513
Tezel G, Wax MB (2003) Glial modulation of retinal ganglion cell death in glaucoma. J Glaucoma 12:63–68
Thanos S, Mey J, Wild M (1993) Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 13:455–466
Wang D, Masutani H, Oka S et al (2006) Control of mitochondrial outer membrane permeabilization and Bcl-xL levels by thioredoxin 2 in DT40 cells. J Biol Chem 281:7384–7391
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Munemasa, Y., Kwong, J.M.K., Kim, S.H., Ahn, J.H., Caprioli, J., Piri, N. (2010). Thioredoxins 1 and 2 Protect Retinal Ganglion Cells from Pharmacologically Induced Oxidative Stress, Optic Nerve Transection and Ocular Hypertension. In: Anderson, R., Hollyfield, J., LaVail, M. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 664. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1399-9_41
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1399-9_41
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1398-2
Online ISBN: 978-1-4419-1399-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)